Postmortem disclosure of genetic information to family members: active or passive?Boers, S. N., van Delden, J. J. M., Knoers, N. V. & Bredenoord, A. L., 2015, In : TRENDS IN MOLECULAR MEDICINE. 21, 3, p. 148-153 6 p.
Research output: Contribution to journal › Review article › Academic › peer-review
Advances in next-generation DNA sequencing (NGS) now make it possible, and affordable, to sequence the entire genome of an individual. Routine clinical application is on the horizon. There is a consensus that some subsets of genetic information should be disclosed to patients, but disclosure to their relatives is less consensual. This issue becomes especially salient after a patient's death, when permission can no longer be sought. There has however been little debate on postmortem disclosure. We identify and explain the arguments in favor of and against disclosure of genetic information to the relatives of a deceased patient. We conclude that there are valid reasons to communicate some subsets of genetic information to family members after death, and we propose a passive postmortem disclosure policy.
|Number of pages||6|
|Journal||TRENDS IN MOLECULAR MEDICINE|
|Publication status||Published - 2015|
- Disclosure, Family, Genetic Privacy, Humans, Postmortem Changes